Last 12 months
Inside the activity.
1 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 1 | 11 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2021 Filed Jun 8, 2021 20:46 UTC |
Brege LauraDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001209191-21-038946 · doc4.xml · derivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:42 UTC |
GREY MICHAEL GDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001209191-21-038941 · doc4.xml · derivative · entry 1 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:38 UTC |
O'Donnell NiallDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001209191-21-038932 · doc4.xml · derivative · entry 1 O'Donnell Niall · CIK 0001780235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting. Read SEC document |
| May 10, 2021 Filed May 12, 2021 17:48 UTC |
Vig PamelaChief Scientific Officer
|
GrantCommon Stock | 699 | $14.62 | $10,219.38 |
DisclosureSEC source: 0001209191-21-032166 · doc4.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 699 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 17:27 UTC |
Clements IanChief Financial Officer
|
GrantCommon Stock | 981 | $14.62 | $14,342.22 |
DisclosureSEC source: 0001209191-21-032139 · doc4.xml · nonDerivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,852 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 981 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:46 UTC |
Tucker Edwin JonathanChief Medical Officer
|
GrantCommon Stock | 1,483 | $14.62 | $21,681.46 |
DisclosureSEC source: 0001209191-21-032163 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,007 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,483 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:45 UTC |
Radovich PeterChief Operating Officer
|
GrantCommon Stock | 1,006 | $14.62 | $14,707.72 |
DisclosureSEC source: 0001209191-21-032160 · doc4.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,512 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,006 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:41 UTC |
Peetz ChristopherDirector · President and CEO
|
GrantCommon STock | 1,453 | $14.62 | $21,242.86 |
DisclosureSEC source: 0001209191-21-032157 · doc4.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,824 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,453 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:38 UTC |
Longpre LaraChief Development Officer
|
GrantCommon Stock | 1,259 | $14.62 | $18,406.58 |
DisclosureSEC source: 0001209191-21-032154 · doc4.xml · nonDerivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,081 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,259 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 23:40 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,082 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-21-018717 · doc4.xml · derivative · entry 2 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,751 Underlying: Common Stock · 1,082 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 23:40 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionCommon Stock | 1,082 | $7.70 | $8,331.40 |
DisclosureSEC source: 0001209191-21-018717 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:34 UTC |
Vig PamelaChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-003026 · doc4.xml · derivative · entry 1 Vig Pamela · CIK 0001780069 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:32 UTC |
Clements IanChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-003022 · doc4.xml · derivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:36 UTC |
Radovich PeterChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-003030 · doc4.xml · derivative · entry 1 Radovich Peter · CIK 0001650131 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:14 UTC |
Tucker Edwin JonathanChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-002988 · doc4.xml · derivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:11 UTC |
Peetz ChristopherDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-002983 · doc4.xml · derivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2021 Filed Mar 9, 2021 00:48 UTC Amendment |
Longpre LaraChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-018772 · doc4a.xml · derivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-01-06 F1 · date: This Form 4 is being amended to correct the transaction date. F2 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:24 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-20-065367 · doc4.xml · derivative · entry 2 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,833 Underlying: Common Stock · 4,167 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:24 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionCommon Stock | 4,167 | $7.70 | $32,085.90 |
DisclosureSEC source: 0001209191-20-065367 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:12 UTC |
Clements IanChief Financial Officer
|
PurchaseCommon Stock | 1,562 | $18.65 | $29,131.30 |
DisclosureSEC source: 0001209191-20-065167 · doc4.xml · nonDerivative · entry 2 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,841 Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:12 UTC |
Clements IanChief Financial Officer
|
PurchaseCommon Stock | 908 | $18.55 | $16,843.40 |
DisclosureSEC source: 0001209191-20-065167 · doc4.xml · nonDerivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,279 Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 21:06 UTC |
Peetz ChristopherDirector · President and CEO
|
PurchaseCommon Stock | 2,000 | $18.60 | $37,200.00 |
DisclosureSEC source: 0001209191-20-065165 · doc4.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Peetz Family Trust Disclosed balance after: 201,570 Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 21:06 UTC |
Peetz ChristopherDirector · President and CEO
|
PurchaseCommon Stock | 3,000 | $18.76 | $56,280.00 |
DisclosureSEC source: 0001209191-20-065165 · doc4.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Peetz Family Trust Disclosed balance after: 199,570 Read SEC document |
| December 23, 2020 Filed Mar 8, 2021 19:42 UTC Amendment |
Clements IanChief Financial Officer
|
PurchaseCommon Stock | 1,592 | $18.65 | $29,690.80 |
DisclosureSEC source: 0001209191-21-018770 · doc4a.xml · nonDerivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,871 F1 · shares: This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction. F1 · balance_after: This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 17:20 UTC |
Vig PamelaChief Scientific Officer
|
GrantCommon Stock | 595 | $15.27 | $9,083.27 |
DisclosureSEC source: 0001209191-20-058054 · doc4.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,207 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 595 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 17:06 UTC |
Clements IanChief Financial Officer
|
GrantCommon Stock | 1,371 | $15.27 | $20,929.69 |
DisclosureSEC source: 0001209191-20-058035 · doc4.xml · nonDerivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,371 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,371 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:14 UTC |
Longpre LaraChief Development Officer
|
GrantCommon Stock | 822 | $15.27 | $12,548.65 |
DisclosureSEC source: 0001209191-20-058048 · doc4.xml · nonDerivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,822 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 822 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:12 UTC |
Tucker Edwin JonathanChief Medical Officer
|
GrantCommon Stock | 1,275 | $15.27 | $19,464.15 |
DisclosureSEC source: 0001209191-20-058044 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,275 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,275 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:16 UTC |
Radovich PeterChief Operating Officer
|
GrantCommon Stock | 861 | $15.27 | $13,144.03 |
DisclosureSEC source: 0001209191-20-058052 · doc4.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,506 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 861 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:03 UTC |
Peetz ChristopherDirector · President and CEO
|
GrantCommon STock | 1,371 | $15.27 | $20,929.69 |
DisclosureSEC source: 0001209191-20-058024 · doc4.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 1,371 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:09 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-20-056690 · doc4.xml · derivative · entry 2 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:09 UTC |
Tucker Edwin JonathanChief Medical Officer
|
Exercise / conversionCommon Stock | 25,000 | $7.70 | $192,500.00 |
DisclosureSEC source: 0001209191-20-056690 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4 is being filed to report an option exercise and hold transaction that does not involve any open market purchase and sale. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:32 UTC |
Mathers Edward TDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036618 · doc4.xml · derivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:20 UTC |
O'Donnell NiallDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036597 · doc4.xml · derivative · entry 1 O'Donnell Niall · CIK 0001780235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:19 UTC |
Heron Patrick JDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036594 · doc4.xml · derivative · entry 1 Heron Patrick J · CIK 0001365617 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:17 UTC |
Fischer LaurentDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036587 · doc4.xml · derivative · entry 1 Fischer Laurent · CIK 0001379344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:15 UTC |
Brege LauraDirector
|
GrantStock Option (right to buy) · Derivative | 14,167 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036581 · doc4.xml · derivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Underlying: Common Stock · 14,167 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:12 UTC |
GREY MICHAEL GDirector
|
GrantStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $16.71 | $0.00 |
DisclosureSEC source: 0001209191-20-036572 · doc4.xml · derivative · entry 1 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-06-10 F1 · derivative.exercise_date: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 23:38 UTC |
Radovich PeterChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $16.26 | $0.00 |
DisclosureSEC source: 0001209191-20-026418 · doc4.xml · derivative · entry 1 Radovich Peter · CIK 0001650131 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2030-04-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after April 28, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of April 28, 2020. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:47 UTC |
Tucker Edwin JonathanChief Medical Officer
|
PurchaseCommon Stock | 2,500 | $11.90 | $29,740.00 |
DisclosureSEC source: 0001209191-20-020665 · doc4.xml · nonDerivative · entry 2 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · price: The weighted average purchase price for the transaction reported was $11.896, and the range of prices were between $11.88 and $11.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:47 UTC |
Tucker Edwin JonathanChief Medical Officer
|
PurchaseCommon Stock | 2,000 | $9.91 | $19,818.00 |
DisclosureSEC source: 0001209191-20-020665 · doc4.xml · nonDerivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 17:35 UTC |
Clements IanChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.24 | $0.00 |
DisclosureSEC source: 0001209191-20-003338 · doc4.xml · derivative · entry 1 Clements Ian · CIK 0001780080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 10, 2020 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 17:45 UTC |
Vig PamelaChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $19.24 | $0.00 |
DisclosureSEC source: 0001209191-20-003348 · doc4.xml · derivative · entry 1 Vig Pamela · CIK 0001780069 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 10, 2020 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:43 UTC |
Tucker Edwin JonathanChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $19.24 | $0.00 |
DisclosureSEC source: 0001209191-20-003345 · doc4.xml · derivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 10, 2020 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:39 UTC |
Longpre LaraChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $19.24 | $0.00 |
DisclosureSEC source: 0001209191-20-003342 · doc4.xml · derivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 10, 2020 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:33 UTC |
Peetz ChristopherDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 170,000 | $0.00 Strike: $19.24 | $0.00 |
DisclosureSEC source: 0001209191-20-003335 · doc4.xml · derivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 10, 2020 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2020 Filed Jan 11, 2021 22:27 UTC |
Longpre LaraChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001209191-21-003002 · doc4.xml · derivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-01-06 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 01, 2020 Filed Jan 2, 2020 21:31 UTC |
GREY MICHAEL GDirector
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $24.52 | $0.00 |
DisclosureSEC source: 0001209191-20-000307 · doc4.xml · derivative · entry 1 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-12-31 F1 · derivative.exercise_date: 1/48th of the shares vest at the end of each month after January 1, 2020. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 20:17 UTC |
Tucker Edwin JonathanChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001209191-19-054240 · doc4.xml · derivative · entry 1 Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-10-23 F1 · derivative.exercise_date: 1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019. Read SEC document |
| September 17, 2019 Filed Sep 18, 2019 21:23 UTC |
Fischer LaurentDirector
|
PurchaseCommon Stock | 1,648 | $9.37 | $15,435.17 |
DisclosureSEC source: 0001209191-19-050105 · doc4.xml · nonDerivative · entry 2 Fischer Laurent · CIK 0001379344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 F2 · price: The weighted average purchase price for the transaction reported was $9.36, and the range of prices were between $9.29 and $9.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.